Altogether, these findings strongly suggest that BC-N102 suppresses breast cancer proliferation via cell cycle arrest by enhancing the activities of cell cycle regulatory protein which in turn inhibit the activities of cell cycle proteins including the CDK2, CDK4 and cyclin D1, and consequently led to cell cycle arrest. Here, CDK4 is linked to breast carcinoma.